Second-line treatment with Axitinib: an effective and well-tolerated weapon in the therapeutic sequence of clear cell renal cell carcinoma. Work Paper Public Hlth [Internet]. 2015 Jun. 15 [cited 2025 Jul. 18];4(1). Available from: https://journals.pagepress.org/wpph/article/view/6697